Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells

Journal of Neuro-Oncology

Volumn 76, Issue 3, 2006, Pages 219-225

  Yao, Yongxue ^a,b   Kubota, Toshihiko ^a   Sato, Kazufumi ^a   Takeuchi, Hiroaki ^a   Handa, Yuji ^a   Matsukawa, Shigeru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Glioma; Interferon; MAPK; VEGF

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; INTERFERON; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; PROTEIN P53; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; RNA STABILITY; UPREGULATION;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYCLOHEXIMIDE; DACTINOMYCIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOBLASTOMA; HUMANS; INTERFERONS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN SYNTHESIS INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645315210     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-6498-5     Document Type: Article

References (37)

1. J Folkman M Klagsbrun 1987 Angiogenic factors Science 135 442-447
2. KH Plate G Breier HA Weich W Risau 1992 Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo Nature 359 845-848 10.1038/359845a0 1:CAS:528:DyaK38XmsV2gsb8%3D 1279432
3. J Hasan R Byers GC Jayson 2002 Intra-tumoural microvessel density in human solid tumours. Br J Cancer 86 1566-1577 10.1038/sj.bjc.6600315 1:STN:280:DC%2BD38zktVehtg%3D%3D 12085206
4. Y Yao T Kubota K Sato R Kitai H Takeuchi H Arishima 2001 Prognostic value of vascular endothelial growth factor and its receptors flt-1 and flk-1 in astrocytic tumours Acta Neurochir 143 159-166 10.1007/ s007010170122 1:STN:280:DC%2BD38%2Fit1Oltw%3D%3D
5. KJ Kim B Li J Winer M Armanini N Gillett HS Phillips N Ferrara 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 841-844 1:CAS:528:DyaK3sXktVKju7s%3D 7683111
6. B Millauer L Shawver KH Plate W Risau A Ullrich 1994 Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367 576-578 10.1038/367576a0 1:CAS:528:DyaK2cXhs1Sgt7w%3D 8107827
7. SA Im C Gomez-Manzano J Fueyo TJ Liu LD Ke JS Kim HY Lee PA Sreck AP Kyritsis WK Yung 1999 Anti-angiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo Cancer Res 59 895-900 1:CAS:528:DyaK1MXht1Siur0%3D 10029081
8. TA Fong LK Shawver L Sun C Tang H App TJ Powell YH Kim R Schreck X Wang W Risau A Ullrich KP Hirth G McMahon 1999 SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types Cancer Res 59 99-106 1:CAS:528:DyaK1MXmsFOgug%3D%3D 9892193
9. E Ikeda MG Achen G Breier W Risau 1995 Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells J Biol Chem 270 19761-19766 10.1074/ jbc.270.44.26460 1:CAS:528:DyaK2MXnvVCmtb4%3D 7544346
10. A Maity N Pore J Lee D Solomon DM O'Rourke 2000 Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia Cancer Res 60 5879-5886 1:CAS:528:DC%2BD3cXnvVSntL8%3D 11059786
11. M Ryuto M Ono H Izumi S Yoshida HA Weich K Kohno M Kuwano 1996 Induction of vascular endothelial growth factor by tumor necrosis factor in human glioma cells J Biol Chem 271 28220-28228 1:CAS:528:DyaK28XmvVWksbc%3D 8910439
12. L Zhang D Yu M Hu S Xiong A Lang LM Ellis RE Pollock 2000 Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression Cancer Res 60 3655-3661 1:CAS:528:DC%2BD3cXkvFChtr0%3D 10910082
13. GR Stark IM Kerr BRG Williams RH Silverman RD Schreiber 1998 How cells respond to interferons Annu Rev Biochem 67 227-264 10.1146/ annurev.biochem.67.1.227 1:CAS:528:DyaK1cXlsFOmsLo%3D 9759489
14. JE Darnell Jr. IM Kerr GR Stark 1994 Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signal proteins Science 264 1415-1421 1:CAS:528:DyaK2cXktlalsL4%3D 8197455
15. MO Kim Q Si JN Zhou RG Pestell CF Brosnan J Locker SC Lee 2002 Interferon-beta activates multiple signaling cascades in primary human microglia J Neurochem 81 1361-1371 10.1046/j.1471-4159.2002.00949.x 1:CAS:528:DC%2BD38XltVWksLw%3D 12068083
16. A Verma DK Deb A Sassano S Kambhampati A Wickrema S Uddin M Mohindru K Besien Van LC Platanias 2002 Cutting edge: Activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia J Immunol 168 5984-5988 1:CAS:528:DC%2BD38XksFWmsb8%3D 12055203
17. MSJ Mahaley L Bertsch S Cush GY Gillespie 1988 Systemic gamma-interferon therapy for recurrent gliomas J Neurosurg 69 826-829 3142970
18. WKA Yung M Prados VA Levin MR Fetell J Bennett M Mahaley M Salcman E Etcubanas 1991 Intravenous recombiant interferon β in patients with recurrent malignant gliomas: A phase I/II study J Clin Oncol 9 1945-1949 1:STN:280:By2D2cvntVM%3D 1658242
19. JC Buckner PJ Schomberg WL McGinnis TL Cascino BW Scheithauer JR O'Fallon RF Morton SA Kuross JA Mailliard AK Hatfield JT Cole PD Steen AM Bernath 2001 A phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma Cancer 92 420-433 10.1002/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO;2-3 1:CAS:528:DC%2BD3MXlvVymsrs%3D 11466698
20. Y Yao T Kubota K Sato H Takeuchi R Kitai S Matsukawa 2005 Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells J Neurooncol 72 3 217-223 10.1007/s11060-004-3012-4 1:CAS:528:DC%2BD28XkvA%3D%3D 15937643
21. A Moghaddam HT Zhang TP Fan DE Hu VC Lees H Turley SB Fox KC Gatter AL Harris R Bicknell 1995 Thymidine phosphorylase is angiogenic and promotes tumor growth Proc Natl Acad Sci USA 92 998-1002 1:CAS:528:DyaK2MXjslehu78%3D 7532308
22. Y Yao T Kubota K Sato R Kitai 2001 Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors Clin Cancer Res 7 4021-4026 1:CAS:528:DC%2BD38XltFSisw%3D%3D 11751496
23. Z Marschall von A Scholz T Cramer G Schafer M Schirner K Oberg B Wiedenmann M Hocker S Rosewicz 2003 Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis J Natl Cancer Inst 95 437-448
24. W-Z Wu H-C Sun Y-F Shen J Chen L Wang Z-Y Tang G Iliakis K-D Liu 2005 Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways J Cancer Res Clin Oncol 131 169-178 1:CAS:528:DC%2BD2MXmsVersA%3D%3D 15662525
25. YK Hong DS Chung YA Joe YJ Yang KM Kim YS Park WKA Yung JK Kang 2000 Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-β treatment at early stage of tumor development Clin Cancer Res 6 3354-3360 1:CAS:528:DC%2BD3cXmsVOmtLY%3D 10955823
26. M Hotfilder H Knupfer G Mohlenkamp P Pennekamp M Knupfers S Gool Van JE Wolff 2000 Interferon-gamma increases IL-6 production in human glioblastoma cell lines Anticancer Res 20 4445-4450 1:CAS:528:DC%2BD3MXhtVejsLo%3D 11205286
27. S Matsushita T Nitanda T Furukawa T Sumizawa A Tani K Nishimoto S Akiba K Miyadera M Fukushima Y Yamada H Yoshida T Kanzaki S Akiyama 1999 The effect of thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors Cancer Res 59 1911-1916 1:CAS:528:DyaK1MXislejtrg%3D 10213500
28. X Wang A Takahashi K Ohnishi H Matsumoto K Suda T Ohnishi 1997 Bifunctional effects of a protein kinase inhibitor (H-7) on heat-induced p53-dependent WAF1 accumulation Exp Cell Res 237 186-191 1:CAS:528:DyaK2sXnvFWlsr8%3D 9417881
29. NS Brown A Jones C Fujiyama AL Harris R Bicknell 2000 Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors Cancer Res 60 6298-6302 1:CAS:528:DC%2BD3cXos1Sktr8%3D 11103787
30. A Takaoka S Hayakawa H Yanai D Stoiber H Negishi H Kikuchi S Sasaki K Imai T Shibue K Honda T Taniguchi 2003 Integration of interferon-α/ β signaling to p53 responses in tumor suppression and antiviral defence Nature 424 516-523 10.1038/nature01850 1:CAS:528:DC%2BD3sXlvVGisLw%3D 12872134
31. C Porta R Hadj-Slimane M Nejmeddine M Pampin MG Tovey L Espert S Alvarez MK Chelbi-Alix 2005 Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively Oncogene 24 605-615 10.1038/ sj.onc.1208204 1:CAS:528:DC%2BD2MXltVSntQ%3D%3D 15580300
32. E Tischer R Mitchell T Hartman M Silva D Gospodarowicz JC Fiddes JA Abraham 1991 The human gene for vascular endothelial growth factor J Biol Chem 266 11947-11954 1:CAS:528:DyaK38XhtVSgtbk%3D 1711045
33. J Milanini J Pouyssegur G Pages 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription J Biol Chem 277 20631-20639
34. G Pages E Berra J Milanini AP Levy J Pouyssegur 2000 Stress-activated protein kinase (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability J Biol Chem 275 26484-26491 1:CAS:528:DC%2BD3cXmt1Oktb4%3D 10849421
35. JE McCarthy H Kollmus 1995 Cytoplasmic mRNA-protein interactions in eukaryotic gene expression Trends Biochem Sci 20 191-197 10.1016/ S0968-0004(00)89006-4 1:CAS:528:DyaK2MXlslGns7o%3D 7610483
36. P Salven T Ruotsalainen K Mattson H Joensuu 1998 High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer Int J Cancer 79 144-146 10.1002/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T 1:STN:280:DyaK1c3ktlSrtA%3D%3D 9583728
37. TM Ruotsalainen K Mattson 2002 Review: Interferon trials in small cell lung cancer at one institution: A comparison of results obtained before and after initiation of systematic treatment trials using IFN-alpha in combination with other modalities J Interferon Cytokine Res 22 165-171 10.1089/107999002753536130 1:CAS:528:DC%2BD38Xjt12itbs%3D 11911799